Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Thermo Fischer Scientific | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: Thermo Fischer Scientific

Laboratory Products and Services Segment revenue up 42% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Thermo Fischer Scientific
1Q Revenues: $5.9 billion (+23%)
1Q Earnings: $579 million (+5%)
Comments: Laboratory Products and Services Segment revenue grew 42% to $2.4 billion, reflecting the acquisition of Patheon in late August 2017. Life Sciences Solutions Segment revenue grew 10% to $1.5 billion. Analytical Instruments Segment revenue grew 19% to $1.3 billion. Specialty Diagnostics Segment revenue grew 9% to $0.95 billion. The company launched new products across our portfolio, including Thermo Scientific Vanquish Duo UHPLC systems for pharma QA/QC, the Thermo Scientific Chromeleon XTR Laboratory Management System and the Ion GeneStudio S5 Series of next-generation sequencing instruments. Acquisitions increased revenue by 12% in the quarter.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters